Panelists discuss how current multiple sclerosis (MS) therapies show limited effectiveness against progression, but emerging ...

Panelists discuss how chronic neuroinflammation involves distinct mechanisms from acute relapses—including microglial ...

While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

This article is the first in a two part article (the second part [1] will be published in an upcoming issue of IEEE Antennas and Propagation Magazine) that presents a bottom-up description of ...